Fabry nephropathy and the case for adjunctive renal therapy

J Am Soc Nephrol. 2007 Sep;18(9):2426-8. doi: 10.1681/ASN.2007070783. Epub 2007 Aug 15.
No abstract available

Publication types

  • Comment
  • Editorial
  • Review

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / therapeutic use*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Drug Therapy, Combination
  • Fabry Disease / complications*
  • Fabry Disease / drug therapy*
  • Humans
  • Kidney Diseases / drug therapy*
  • Kidney Diseases / etiology
  • Recombinant Proteins / therapeutic use
  • alpha-Galactosidase / therapeutic use*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Recombinant Proteins
  • alpha-Galactosidase